TC BioPharm

📍 Holytown, United Kingdom🗓 Founded 2014👥 53 employees💰 Last funded Jan 2020
Biotechnology Research🌐 tcbiopharm.com
Website LinkedIn
TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
United Kingdom
1
Frequently asked questions
Who invested in TC BioPharm?
TC BioPharm has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did TC BioPharm last raise funding?
The most recent investment in TC BioPharm recorded on gritt.io was in January 2020.
When was TC BioPharm founded?
TC BioPharm was founded in 2014.
What industry is TC BioPharm in?
TC BioPharm operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is TC BioPharm based?
TC BioPharm is headquartered in Holytown, United Kingdom.